---

---

tags : Disease    symbols : Glaxf   

save search

---

Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published: 2024-02-14 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| -5.48% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| 1.1% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | News | $135.35 -3.53% -4.19% 400 |

Health Technology

| 9.6% | O: 0.87% H: 0.21% C: -2.23%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| -1.28% | O: 0.89% H: 0.41% C: 0.1%
LLY | News | $732.2 -1.81% -0.84% 1.7M |

Health Technology

| 1.24% | O: 0.38% H: 2.44% C: 1.54%
VRTX | $400.76 -1.03% -1.06% 810K |

Health Technology

| -3.67% | O: 0.56% H: 0.49% C: -0.12%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 2.76% | O: -1.1% H: 0.0% C: 0.0%
BIIB | $201.99 4.56% 4.32% 2.7M |

Health Technology

| -10.88% | O: 0.16% H: 0.43% C: -2.76%
AZN | News | $71.2 0.49% 0.46% 5.4M |

Health Technology

| 16.66% | O: 0.28% H: 0.93% C: 0.75%
AMGN | News | $273.01 -0.19% -0.17% 1.5M |

Health Technology

| -6.01% | O: -0.21% H: 0.34% C: 0.07%
disease report treatment expansion global infections market

---

Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published: 2023-12-06 (Crawled : 15:30) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| 12.08% | O: 1.64% H: 0.0% C: -1.33%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 1.42% | O: 0.52% H: 0.18% C: -0.43%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| 12.47% | O: -0.03% H: 0.28% C: -0.41%
LLY | News | $732.2 -1.81% -0.84% 1.7M |

Health Technology

| 29.05% | O: 0.99% H: 0.0% C: 0.0%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 16.07% | O: 0.26% H: 0.0% C: 0.0%
DNLI | $15.56 -3.41% -3.6% 940K |

Health Technology

| -16.07% | O: 0.05% H: 5.74% C: 3.18%
BIIB | $201.99 4.56% 4.32% 2.7M |

Health Technology

| -12.01% | O: 0.42% H: 2.37% C: 1.45%
disease parkinson's revenue research therapeutics market

---

Unraveling the Shifting Rare Eye Diseases Market Landscape: Analysis of Retinoblastoma Market, Retinitis Pigmentosa Market, Limbal Stem Cell Deficiency Market, Leber Hereditary Optic Neuropathy Market, and Stargardt Disease Market | DelveInsight
Published: 2023-11-16 (Crawled : 22:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| 15.74% | O: -2.04% H: 0.0% C: 0.0%
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| 1.62% | O: 1.01% H: 0.0% C: -2.65%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| 3.67% | O: 0.67% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 4.56% | O: 0.91% H: 0.21% C: -0.01%
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -0.92% | O: 0.78% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| 18.64% | O: 1.05% H: 1.44% C: 1.15%
ABT | News | $106.89 -0.65% -0.09% 4.2M |

Health Technology

| 9.12% | O: 2.58% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 3.01% | O: 1.42% H: 0.0% C: 0.0%
rare disease cell eye market

---

Conquering Challenges in the Solid Tumor Market: Your Guide to FDA-EMA Indications, Regulatory Compliance, and Market Access Excellence | Disease Landscape Insights
Published: 2023-09-21 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 400 |

Health Technology

| -0.73% | O: -1.13% H: 0.0% C: -0.63%
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -8.4% | O: 0.52% H: 0.57% C: -0.56%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| 7.33% | O: -0.5% H: 0.26% C: -0.69%
LLY | News | $732.2 -1.81% -0.84% 1.7M |

Health Technology

| 31.1% | O: -1.47% H: 0.0% C: 0.0%
BMY | $48.86 -0.27% 0.98% 14M |

Health Technology

| -16.88% | O: -0.37% H: 1.54% C: 0.89%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 9.15% | O: -0.04% H: 0.76% C: -0.16%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -14.37% | O: -1.16% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 5.4M |

Health Technology

| 4.77% | O: 0.19% H: 0.03% C: -1.57%
AMGN | News | $273.01 -0.19% -0.17% 1.5M |

Health Technology

| 0.57% | O: 0.22% H: 0.15% C: -0.98%
disease tumor market

---

Inflammatory Bowel Disease Market to grow by USD 7,687.43 million from 2022 to 2027; The increasing demand for biologics and targeted therapies drives the market - Technavio
Published: 2023-08-16 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| 17.73% | O: 5.46% H: 0.0% C: -2.87%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| 11.1% | O: -0.67% H: 0.0% C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 4.4M |

Health Technology

| 3.49% | O: -0.99% H: 1.45% C: 1.36%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| -4.13% | O: -0.2% H: 0.34% C: -0.26%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| 15.88% | O: -0.77% H: 0.79% C: 0.17%
BAX | $40.93 -0.22% 0.0% 2.2M |

Health Technology

| -3.35% | O: -0.4% H: 0.73% C: -0.24%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 10.66% | O: 0.56% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.09% 4.2M |

Health Technology

| 0.94% | O: -1.36% H: 0.88% C: 0.07%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -10.85% | O: -1.33% H: 0.0% C: 0.0%
disease market

---

Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2023: Increasing Prevalence of Lung Disease Drives Growth
Published: 2023-06-28 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| 15.47% | O: 1.75% H: 0.06% C: 0.06%
AZNCF | News | $135.35 -3.53% -4.19% 400 |

Health Technology

| -3.6% | O: 1.06% H: 0.72% C: 0.72%
ALPMY | News | $9.47 -0.21% -1.11% 400K |

Manufacturing

| -37.57% | O: -1.98% H: 0.0% C: -0.47%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| -0.09% | O: 0.17% H: 0.85% C: 0.76%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| 15.0% | O: -1.21% H: 1.17% C: 0.91%
ABT | News | $106.89 -0.65% -0.09% 4.2M |

Health Technology

| -0.67% | O: -0.54% H: 0.78% C: 0.59%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -12.09% | O: -1.86% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 5.4M |

Health Technology

| 0.34% | O: -0.83% H: 0.89% C: 0.68%
lung disease report treatment global growth market

---

Gastrointestinal Drugs Market Research Report by Drug Category, Route of Administration, Disease Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-23 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| 10.89% | O: -3.13% H: 0.0% C: -0.23%
TAK | News | $13.23 -1.12% 0.0% 920K |

Health Technology

| -14.2% | O: 0.13% H: 0.71% C: 0.65%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| 15.72% | O: -0.14% H: 0.28% C: -0.11%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -1.32% | O: -0.23% H: 0.0% C: 0.0%
covid-19 drug research global disease report impact gastrointestinal market

---

Addisons disease therapeutics market size to increase by USD 442 million: 41% growth to originate from North America - Technavio
Published: 2022-12-14 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| 11.58% | O: -1.57% H: 2.23% C: 2.23%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 6.29% | O: -0.71% H: 0.08% C: -1.07%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| 13.75% | O: 0.36% H: 0.28% C: -1.17%
ABT | News | $106.89 -0.65% -0.09% 4.2M |

Health Technology

| -3.93% | O: -1.27% H: 0.14% C: -1.21%
TECH | $63.52 -0.27% -0.33% 980K |

Health Technology

| -26.83% | O: -1.84% H: 0.92% C: -1.2%
BIIB | $201.99 4.56% 4.32% 2.7M |

Health Technology

| -30.12% | O: -0.51% H: 0.11% C: -1.44%
AMGN | News | $273.01 -0.19% -0.17% 1.5M |

Health Technology

| 0.69% | O: -0.25% H: 0.25% C: -1.59%
america disease therapeutics growth market

---

Sexually transmitted disease (STD) testing market size to grow by USD 29,988.27 Million: Increasing prevalence of STDs remains key growth driver - Technavio
Published: 2022-12-07 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| 12.08% | O: 1.92% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| 10.79% | O: -1.41% H: 1.75% C: 0.66%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 1.45% | O: 0.0% H: 0.5% C: 0.36%
disease growth market

---

Non-steroidal Anti-inflammatory Drugs Market Research Report by Disease Indication, Drugs, Route of Administration, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-07 (Crawled : 16:00) - prnewswire.com
RBGPF | News | $53.94 3.53% 6.46% 3.4K |

Consumer Non-Durables

| -23.78% | O: 0.06% H: 3.15% C: 0.15%
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| 5.31% | O: 0.74% H: 0.0% C: -6.74%
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| -3.17% | O: 1.62% H: 0.0% C: -4.28%
AZNCF | News | $135.35 -3.53% -4.19% 400 |

Health Technology

| -1.02% | O: -0.56% H: 0.61% C: 0.01%
RBGLY | News | $10.98 2.0% -2.05% 860K |

Manufacturing

| -24.72% | O: 0.51% H: 0.48% C: -0.14%
VTRS | News A | $11.55 1.67% 1.65% 4.4M |

Health Technology

| 5.67% | O: 0.0% H: 0.55% C: -0.27%
ZTS | $150.88 0.88% 0.68% 3.2M |

Health Technology

| -1.42% | O: -0.06% H: 0.54% C: -1.77%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -1.58% | O: -0.09% H: 0.47% C: -0.28%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| 7.75% | O: -0.98% H: 0.24% C: -1.78%
LLY | News | $732.2 -1.81% -0.84% 1.7M |

Health Technology

| 104.11% | O: 0.21% H: 1.6% C: 0.72%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| 5.15% | O: 5.18% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 5.4M |

Health Technology

| 3.85% | O: 0.45% H: 0.64% C: -0.03%
covid-19 research global disease report impact distribution market

---

The Global Addison's Disease Therapeutics Market is expected to grow by $442 mn from 2023-2027, accelerating at a CAGR of 6.93% during the forecast period
Published: 2022-11-30 (Crawled : 16:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| 19.08% | O: -0.06% H: 0.06% C: -1.08%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| 31.96% | O: 1.83% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 12.58% | O: 1.22% H: 1.37% C: 1.28%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| 18.92% | O: 0.09% H: 0.58% C: 0.58%
ABT | News | $106.89 -0.65% -0.09% 4.2M |

Health Technology

| 1.8% | O: 0.12% H: 2.44% C: 2.33%
BIIB | $201.99 4.56% 4.32% 2.7M |

Health Technology

| -30.69% | O: 5.1% H: 1.83% C: -0.36%
AMGN | News | $273.01 -0.19% -0.17% 1.5M |

Health Technology

| -3.18% | O: 0.2% H: 1.91% C: 1.36%
global disease expected therapeutics market

---

Parkinson's Disease Drugs Market to Reach $10.4 Bn, Globally, by 2031 at 6.2% CAGR: Allied Market Research
Published: 2022-11-17 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| 22.15% | O: 0.98% H: 0.0% C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 4.4M |

Health Technology

| 4.24% | O: -1.62% H: 1.01% C: 0.55%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 17.71% | O: -1.56% H: 1.64% C: 1.47%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| 24.16% | O: -2.04% H: 1.21% C: 1.09%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 10.49% | O: -0.59% H: 1.39% C: 0.79%
BIIB | $201.99 4.56% 4.32% 2.7M |

Health Technology

| -32.67% | O: -0.98% H: 1.97% C: 1.68%
research disease parkinson's market

---

USD 45.37 Mn incremental growth expected in Darier Disease Drugs Market -- Driven by an increase in demand for advanced dermatological diagnosis
Published: 2022-09-29 (Crawled : 03:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| 31.63% | O: -3.32% H: 4.73% C: 4.73%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| 54.88% | O: 1.87% H: 0.0% C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 4.4M |

Health Technology

| 32.3% | O: -1.26% H: 0.7% C: -0.23%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 28.87% | O: 0.17% H: 1.1% C: 0.16%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| 38.7% | O: -0.14% H: 0.53% C: -0.2%
BHC | $8.56 0.35% 0.47% 1.1M |

Health Technology

| 14.59% | O: -1.2% H: 0.0% C: -5.83%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 16.04% | O: 0.17% H: 0.28% C: -1.47%
disease expected dermatological growth market

---

Global Chronic Obstructive Pulmonary Disease Treatment Market to Surpass US$ 25,601.45 Million by 2030 - Coherent Market Insights
Published: 2022-09-08 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| 30.51% | O: 2.63% H: 0.0% C: -3.84%
AZNCF | News | $135.35 -3.53% -4.19% 400 |

Health Technology

| 18.98% | O: 6.1% H: 0.13% C: -1.44%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| 44.0% | O: 0.0% H: 0.0% C: -1.42%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 21.51% | O: -0.75% H: 1.17% C: 1.16%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| 29.76% | O: -1.84% H: 2.04% C: 1.94%
AZN | News | $71.2 0.49% 0.46% 5.4M |

Health Technology

| 19.02% | O: -0.47% H: 1.85% C: 1.31%
treatment global disease market

---

Global Acquired von Willebrand Disease (AvWD) Treatment Market Report 2022-2030 Featuring Key Players - Novo Nordisk A/S, Genentech, Inc., F. Hoffman-La Roche AG, Sanofi SA
Published: 2022-07-25 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| -7.67% | O: 0.0% H: 0.0% C: 0.0%
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| 10.08% | O: 0.83% H: 0.67% C: 0.32%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| -3.38% | O: 0.76% H: 0.19% C: -1.06%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -4.04% | O: 2.0% H: 0.0% C: 0.0%
treatment global disease report roche acquired sanofi market

---

Breakthroughs In Treating Killer Diseases Could Lengthen Life
Published: 2022-06-07 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| -27.82% | O: 0.0% H: 0.86% C: 0.84%
AZNCF | News | $135.35 -3.53% -4.19% 400 |

Health Technology

| 7.76% | O: 4.83% H: 0.0% C: -5.0%
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -16.42% | O: -0.18% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| -4.56% | O: 0.37% H: 3.03% C: 2.98%
LLY | News | $732.2 -1.81% -0.84% 1.7M |

Health Technology

| 139.05% | O: -3.62% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 5.4M |

Health Technology

| 12.09% | O: 0.54% H: 2.78% C: 2.69%
life disease

---

Parkinson's Disease (PD) Drugs market - 37% of Growth to Originate from Europe | Evolving Opportunities with AbbVie Inc. & Amneal Pharmaceuticals Inc. | Technavio
Published: 2022-05-18 (Crawled : 07:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 11.61% | O: -0.31% H: 0.53% C: -0.19%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| -8.32% | O: -0.43% H: 0.0% C: 0.0%
BHC | $8.56 0.35% 0.47% 1.1M |

Health Technology

| -22.53% | O: -0.72% H: 1.09% C: -9.3%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 8.22% | O: -0.17% H: 0.59% C: -1.52%
ACAD | News | $16.59 -0.9% -1.03% 1.3M |

Health Technology

| -3.43% | O: -3.61% H: 1.39% C: -3.14%
europe disease growth market

---

USD 438.03 Mn growth expected in Krabbe Disease Treatment Market | North America to emerge as key market | Technavio
Published: 2022-04-28 (Crawled : 16:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380 |

Health Technology

| 40.13% | O: 1.95% H: 0.0% C: 0.0%
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| -29.8% | O: -3.19% H: 1.56% C: 1.56%
NVSEF | News | $96.0 0.94% 6.88% 0 |

Health Technology

| 27.08% | O: -0.44% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 10.0% | O: -0.38% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| -10.08% | O: -0.59% H: 0.0% C: 0.0%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 7.45% | O: 0.6% H: 0.0% C: 0.0%
america treatment disease growth market

---

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets, 2020-2021 & 2026
Published: 2022-04-25 (Crawled : 12:00) - prnewswire.com
ALPMF | News | $9.5 -2.56% 43.47% 21K |

Health Technology

| -40.06% | O: -2.78% H: 0.0% C: 0.0%
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| -27.59% | O: -0.99% H: 0.0% C: -0.11%
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| -14.06% | O: 0.27% H: 0.0% C: 0.0%
MNKKQ | $0.02 |

Manufacturing

| -81.52% | O: -2.96% H: 2.29% C: -6.57%
ALPMY | News | $9.47 -0.21% -1.11% 400K |

Manufacturing

| -40.44% | O: -0.1% H: 0.35% C: -0.09%
VTRS | News A | $11.55 1.67% 1.65% 4.4M |

Health Technology

| 8.15% | O: -5.01% H: 0.0% C: 0.0%
NVS | News | $98.35 1.1% 0.69% 2.1M |

Health Technology

| 8.73% | O: -0.67% H: 0.0% C: 0.0%
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -18.87% | O: 0.01% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| -9.66% | O: -1.57% H: 1.5% C: 1.39%
BSX | $72.91 5.68% 0.0% 13M |

Health Technology

| 58.36% | O: -4.95% H: 2.32% C: 1.9%
BHC | $8.56 0.35% 0.47% 1.1M |

Health Technology

| -61.32% | O: -3.12% H: 0.37% C: 0.19%
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| 6.52% | O: -2.17% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -13.97% | O: -2.01% H: 0.0% C: 0.0%
NMRD | $0.065 8.33% -28.78% 44K |

Health Technology

| -97.87% | O: 17.02% H: 0.52% C: -2.6%
AMGN | News | $273.01 -0.19% -0.17% 1.5M |

Health Technology

| 7.26% | O: -1.38% H: 0.65% C: 0.46%
device disease

---

Gastrointestinal Diseases Therapeutics Market to record USD 22.82 Bn growth | Evolving Opportunities with Abbott Laboratories and AbbVie Inc. | Technavio
Published: 2022-04-15 (Crawled : 11:00) - prnewswire.com
AZN | News | $71.2 0.49% 0.46% 5.4M |

Health Technology

| Email alert Add to watchlist
GSK | News | $40.86 -0.92% 1.25% 1.6M |

Health Technology

| Email alert Add to watchlist
BHC | $8.56 0.35% 0.47% 1.1M |

Health Technology

| Email alert Add to watchlist
GLAXF | News | $19.54 -3.77% -14.18% 170 |

Health Technology

| Email alert Add to watchlist
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $135.35 -3.53% -4.19% 400 |

Health Technology

| Email alert Add to watchlist
ABT | News | $106.89 -0.65% -0.09% 4.2M |

Health Technology

| Email alert Add to watchlist
ABBV | News | $167.8 -1.03% -0.02% 2.9M |

Health Technology

| Email alert Add to watchlist
gastrointestinal therapeutics growth market disease

---

Gainers vs Losers

61%

39%

Top 10 Gainers

CSSE 4 | $0.4253 179.25% 64.77% 210M |

Consumer Services

BOF | $2.08 77.78% 41.21% 110M |

ILAG | $0.54 12.27% 40.62% 3.7M |

LICN | $0.999 78.39% 40.49% 15M |

AMST | $3.4 70.0% 39.58% 70M |

Technology Services

MTC | $3.6 60.71% 38.04% 9.1M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.458 14.5% 30.92% 91K |

Health Services

WHLM | $6.25 35.87% 28.46% 700K |

Commercial Services

MULN | News | $3.77 38.1% 27.78% 13M |

Information

---

Your saved searches

---